Apex Healthcare Berhad (KLSE:AHEALTH)

Apex Healthcare Berhad Ratios and Metrics

Market cap in millions MYR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,729	1,779	1,789	1,681	1,281	1,682
Market Cap Growth	-19.92%	-0.55%	6.40%	31.22%	-23.83%	59.11%
Enterprise Value	1,554	1,627	1,420	1,545	1,130	1,548
Last Close Price	2.40	2.38	2.19	2.01	1.48	1.91
PE Ratio	25.21	23.24	4.49	16.65	21.56	30.02
Forward PE	20.40	18.27	18.68	20.09	20.71	27.70
PS Ratio	1.81	1.85	1.91	1.92	1.66	2.41
PB Ratio	2.15	2.25	1.95	3.01	2.53	3.59
P/TBV Ratio	2.17	2.27	1.95	3.02	2.54	3.61
P/FCF Ratio	24.42	43.35	45.56	40.26	25.19	24.14
P/OCF Ratio	19.29	25.78	27.44	23.33	20.72	19.67
PEG Ratio	2.83	0.87	0.81	1.29	4.14	4.70
EV/Sales Ratio	1.63	1.69	1.52	1.76	1.47	2.22
EV/EBITDA Ratio	13.68	13.22	14.87	15.00	13.98	20.67
EV/EBIT Ratio	17.07	15.63	18.02	17.61	17.20	25.93
EV/FCF Ratio	21.94	39.65	36.16	37.00	22.21	22.22
Debt / Equity Ratio	0.07	0.07	0.01	0.03	0.04	0.06
Debt / EBITDA Ratio	0.41	0.45	0.11	0.15	0.26	0.37
Debt / FCF Ratio	0.74	1.39	0.27	0.38	0.42	0.40
Asset Turnover	0.95	0.90	1.00	1.23	1.19	1.16
Inventory Turnover	5.27	5.68	6.07	6.61	6.51	6.17
Quick Ratio	2.70	2.49	3.03	2.07	2.33	2.16
Current Ratio	3.60	3.32	3.70	2.72	2.97	2.82
Return on Equity (ROE)	8.44%	8.96%	53.90%	18.96%	12.19%	12.54%
Return on Assets (ROA)	6.56%	6.11%	5.27%	7.69%	6.31%	6.19%
Return on Capital (ROIC)	7.86%	7.33%	6.55%	9.95%	8.02%	7.84%
Return on Capital Employed (ROCE)	12.30%	12.30%	8.50%	15.30%	12.40%	12.40%
Earnings Yield	3.94%	4.30%	22.25%	6.01%	4.64%	3.33%
FCF Yield	4.10%	2.31%	2.20%	2.48%	3.97%	4.14%
Dividend Yield	3.75%	3.79%	2.29%	2.15%	2.48%	1.57%
Payout Ratio	95.19%	79.95%	8.72%	28.36%	42.45%	31.30%
Buyback Yield / Dilution	-0.08%	-0.09%	-0.16%	-0.33%	0.14%	-0.34%
Total Shareholder Return	3.67%	3.69%	2.13%	1.83%	2.63%	1.23%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.